Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced U.K. Medicines and Healthcare Products Regulatory Agency ...

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine ...

Scientists from Kolkata-based Bose Institute have created GlowCas9--a CRISPR protein that lights up while performing gene ...

For CPG brands already navigating evolving standards around transparency, sustainability and ingredient innovation, gene ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

Chandigarh: The India International Science Festival (IISF) 2025 culminated Tuesday with sessions on celebrating Nari Shakti ...

A Japanese government expert panel agreed Thursday to legally ban and penalize research or medical practices that genetically ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

VALANX Biotech (VALANX), a biotech company developing novel antibody-drug-conjugate (ADC) assets enabled by its GoldenSite™ site-specific protein conjugation technology, today announced the formation ...

In October 2025, Karolinska Institutet launched a brand-new two-week course giving PhD students a unique insight into how ...